Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Cash from Investing (Quarterly): 10.08M for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 10.08M |
| June 30, 2023 | -51.94M |
| March 31, 2023 | -15.76M |
| December 31, 2022 | -11.13M |
| September 30, 2022 | -12.30M |
| June 30, 2022 | -3.161M |
| Date | Value |
|---|---|
| March 31, 2022 | -90.70M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-90.70M
Minimum
Mar 2022
10.08M
Maximum
Sep 2023
-15.90M
Average
-3.161M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 92.44M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.03M |
| Free Cash Flow | -49.70M |
| Free Cash Flow Per Share (Quarterly) | -0.2529 |